IOVENITTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 721
EU - Europa 617
AS - Asia 91
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.433
Nazione #
US - Stati Uniti d'America 719
GB - Regno Unito 203
IT - Italia 131
IE - Irlanda 123
SE - Svezia 54
CN - Cina 53
UA - Ucraina 30
FR - Francia 25
DE - Germania 15
TR - Turchia 13
VN - Vietnam 12
ES - Italia 11
BE - Belgio 9
FI - Finlandia 6
SG - Singapore 4
CZ - Repubblica Ceca 3
RU - Federazione Russa 3
BR - Brasile 2
CA - Canada 2
HK - Hong Kong 2
MY - Malesia 2
RO - Romania 2
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
PH - Filippine 1
PT - Portogallo 1
Totale 1.433
Città #
Southend 188
Dublin 119
Fairfield 105
Chandler 65
Siena 65
Woodbridge 55
Ashburn 50
Ann Arbor 47
Seattle 40
Wilmington 37
Cambridge 36
Menlo Park 33
Jacksonville 32
Houston 31
New York 23
Dearborn 19
Princeton 17
Phoenix 15
Beijing 13
Nanjing 13
Dong Ket 12
Izmir 10
Málaga 10
Brussels 9
Redwood City 9
Milan 8
San Diego 8
San Mateo 8
Shanghai 8
Fremont 7
Kunming 5
Boardman 4
Cagliari 4
Helsinki 4
Catania 3
Hebei 3
London 3
Moscow 3
Sesto San Giovanni 3
Acerra 2
Bucharest 2
Kuala Lumpur 2
Manchester 2
Nanchang 2
San Francisco 2
Shenyang 2
Viterbo 2
Yenibosna 2
Amman 1
Baghdad 1
Bologna 1
Brno 1
Cairo 1
Central 1
Changsha 1
Chiswick 1
Cologno Monzese 1
Ergolding 1
Florence 1
Hefei 1
Hong Kong 1
Jinan 1
Lancaster 1
Lariano 1
Madrid 1
Manila 1
Montevarchi 1
Monza 1
Munich 1
Napoli 1
Nardò 1
Ningbo 1
Norwalk 1
Olomouc 1
Prague 1
Prescot 1
Quzhou 1
Singapore 1
Tianjin 1
Toronto 1
Winnipeg 1
Zanjan 1
Totale 1.176
Nome #
Prodrugs of pyrazolo[3,4-d]pyrimidines: from library synthesis to evaluation as potential anticancer agents in an orthotopic glioblastoma model 259
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 210
Functionalized Graphene Derivatives: Antibacterial Properties and Cytotoxicity 189
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4- d]pyrimidines for Targeting Hepatocellular Carcinoma 159
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides 145
Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties in cancer therapy: nanosystem and prodrugs approaches 140
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 99
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma 98
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 91
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma 48
Proteins from Tenebrio molitor: an interesting functional ingredient and a source of ACE inhibitory peptides 30
null 14
Totale 1.482
Categoria #
all - tutte 4.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020354 40 18 14 47 38 36 34 40 27 30 14 16
2020/2021251 9 19 10 22 22 23 21 31 9 54 13 18
2021/2022204 17 20 23 5 12 9 6 8 18 29 21 36
2022/2023216 12 28 26 30 17 38 12 16 11 11 12 3
2023/2024238 14 3 11 12 9 57 75 21 3 7 8 18
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 1.482